BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vaz de Paula CB, Nagashima S, Liberalesso V, Collete M, da Silva FPG, Oricil AGG, Barbosa GS, da Silva GVC, Wiedmer DB, da Silva Dezidério F, Noronha L. COVID-19: Immunohistochemical Analysis of TGF-β Signaling Pathways in Pulmonary Fibrosis. Int J Mol Sci 2021;23:168. [PMID: 35008594 DOI: 10.3390/ijms23010168] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 13.0] [Reference Citation Analysis]
Number Citing Articles
1 Salkin H, Acar MB, Gonen ZB, Basaran KE, Ozcan S. Comparative proteomics analysis of transforming growth factor-beta1-overexpressed human dental pulp stem cell-derived secretome on CD44-mediated fibroblast activation via canonical smad signal pathway. Connective Tissue Research 2022. [DOI: 10.1080/03008207.2022.2144733] [Reference Citation Analysis]
2 Karadeniz H, Avanoğlu Güler A, Özger HS, Yıldız PA, Erbaş G, Bozdayı G, Deveci Bulut T, Gülbahar Ö, Yapar D, Küçük H, Öztürk MA, Tufan A. The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients. Biomark�Insights 2022;17:117727192211354. [DOI: 10.1177/11772719221135443] [Reference Citation Analysis]
3 Hirawat R, Jain N, Aslam Saifi M, Rachamalla M, Godugu C. Lung Fibrosis: Post-COVID-19 Complications and Evidences. International Immunopharmacology 2022. [DOI: 10.1016/j.intimp.2022.109418] [Reference Citation Analysis]
4 Islam MA, Getz M, Macklin P, Versypt ANF. An agent-based modeling approach for lung fibrosis in response to COVID-19. bioRxiv 2022:2022. [PMID: 36238719 DOI: 10.1101/2022.10.03.510677] [Reference Citation Analysis]
5 Krysko O, Bourne JH, Kondakova E, Galova EA, Whitworth K, Newby ML, Bachert C, Hill H, Crispin M, Stamataki Z, Cunningham AF, Pugh M, Khan AO, Rayes J, Vedunova M, Krysko DV, Brill A. Severity of SARS-CoV-2 infection is associated with high numbers of alveolar mast cells and their degranulation. Front Immunol 2022;13:968981. [DOI: 10.3389/fimmu.2022.968981] [Reference Citation Analysis]
6 Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G. Host and microbiome features of secondary infections in lethal covid-19. iScience 2022;25:104926. [PMID: 35992303 DOI: 10.1016/j.isci.2022.104926] [Reference Citation Analysis]
7 Federico M. How Do Anti-SARS-CoV-2 mRNA Vaccines Protect from Severe Disease? IJMS 2022;23:10374. [DOI: 10.3390/ijms231810374] [Reference Citation Analysis]
8 Jiang Y, Zhao T, Zhou X, Xiang Y, Gutierrez‐castrellon P, Ma X. Inflammatory pathways in COVID‐19: Mechanism and therapeutic interventions. MedComm 2022;3. [DOI: 10.1002/mco2.154] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Yuan J, Zhu Y, Zhao J, Li L, Zhu C, Chen M, Zhang Y, Shang Y. Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation Studies of the Molecular Targets and Mechanisms of ChuanKeZhi in the Treatment of COVID-19. Natural Product Communications 2022;17:1934578X2211169. [DOI: 10.1177/1934578x221116977] [Reference Citation Analysis]
10 Xu Z, Jiang X, Dai X, Li B. The Dynamic Role of FOXP3+ Tregs and Their Potential Therapeutic Applications During SARS-CoV-2 Infection. Front Immunol 2022;13:916411. [DOI: 10.3389/fimmu.2022.916411] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Solopov PA, Colunga Biancatelli RML, Catravas JD. Alcohol Increases Lung Angiotensin-Converting Enzyme 2 Expression and Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Subunit 1-Induced Acute Lung Injury in K18-hACE2 Transgenic Mice. Am J Pathol 2022;192:990-1000. [PMID: 35483427 DOI: 10.1016/j.ajpath.2022.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Du Q, Wu X, An L, Zhou R, Xiao X, Wu C, Wang F, Yang H. Therapeutic Effect of Astragali Radix Extract Injection Combined with Bone Marrow Mesenchymal Stem Cells in Bleomycin-Induced Pulmonary Fibrotic Rats. Evid Based Complement Alternat Med 2022;2022:4933255. [PMID: 35733628 DOI: 10.1155/2022/4933255] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Manolescu D, Timar B, Bratosin F, Rosca O, Citu C, Oancea C. Predictors for COVID-19 Complete Remission with HRCT Pattern Evolution: A Monocentric, Prospective Study. Diagnostics 2022;12:1397. [DOI: 10.3390/diagnostics12061397] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
14 Bergantini L, Mainardi A, d’Alessandro M, Cameli P, Bennett D, Bargagli E, Sestini P. Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review. Front Pharmacol 2022;13:748931. [DOI: 10.3389/fphar.2022.748931] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Zacharias M, Kashofer K, Wurm P, Regitnig P, Schütte M, Neger M, Ehmann S, Marsh LM, Kwapiszewska G, Loibner M, Birnhuber A, Leitner E, Thüringer A, Winter E, Sauer S, Pollheimer MJ, Vagena FR, Lackner C, Jelusic B, Ogilvie L, Durdevic M, Timmermann B, Lehrach H, Zatloukal K, Gorkiewicz G. Host and microbiome features of secondary infections in lethal covid-19.. [DOI: 10.1101/2022.02.18.22270995] [Reference Citation Analysis]
16 Boraldi F, Lofaro FD, Cossarizza A, Quaglino D. The "Elastic Perspective" of SARS-CoV-2 Infection and the Role of Intrinsic and Extrinsic Factors. Int J Mol Sci 2022;23:1559. [PMID: 35163482 DOI: 10.3390/ijms23031559] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]